KD 1.2 million allocated for importing “Remdesivir”

This news has been read 21563 times!

KUWAIT CITY, Dec 15: While the number of COVID-19 cases receiving intensive care treatments is witnessing a continuous decline during the last period reaching 57 cases, informed sources from the Ministry of Health revealed that the ministry has allocated about KD 1.2 million for importing the drug “Remdesivir”, which is given to patients infected with COVID-19 in the public hospital wards, reports Al-Qabas daily.

They affirmed the ministry’s keenness to provide the best and most modern medicines and medical equipment to deal with the COVID-19 pandemic before and after the crisis.

The sources said, “The Remdesivir drug is still used for the treatment of COVID-19 patients in the wards designated for them in hospitals. It is not given to intensive care patients, as medical recommendations indicate the need to give it to patients with mild to moderate symptoms, as well as those who reach the stage of severe pneumonia and have low oxygen levels.

The medicine is administered by injecting the patient. It also reduces the duration of treatment for COVID-19 symptoms to about a third.

It is given to COVID-19 patients who are adults and children aged 12 and above, and those weighing 40 kilograms or more. It is the first drug that showed relative effectiveness in reducing the number of recovery days for the patient”

This news has been read 21563 times!